Baxter International Inc.

Headquarters: Deerfield, IL, United States

Founded: 1931

Employees: 60,000

CEO: Mr. Jose E. Almeida

NYSE: BAX -0.65%

Market Cap

$19.60 Billion

USD as of Jan. 1, 2024

Market Cap History

Baxter International Inc. market capitalization over time

Evolution of Baxter International Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Baxter International Inc.

Detailed Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Baxter International Inc. has the following listings and related stock indices.

Stock: NYSE: BAX wb_incandescent

Stock: Bovespa: B1AX34 wb_incandescent

Stock: FSX: BTL wb_incandescent

Stock: SIX: BAX wb_incandescent

Product & Services

Medical supplies to treat hemophilia and kidney disease and provide intravenous therapy

Key People

Founder(s): Donald Baxter

José E. Almeida, (chairman & CEO) Jay Saccaro, (CFO)


Revenue: US$11.67B (FY 2020)

Net income: US$1.10B (FY 2020)

Total assets: US$20.01B (FY 2020)

Total equity: US$8.69B (FY 2020)



One Baxter Parkway

Deerfield, IL 60015

United States

Phone: 224 948 2000